secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001558370-22-005126
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path appoints Aline Sherwood to board, regains Nasdaq compliance
--------------------------------------------------------------------

- Aline Sherwood appointed to Bio-Path board effective March 31, 2022, filling vacancy left by Martina Molsbergen's Feb 14 resignation.
- Sherwood named to audit, compensation, nominating/corporate governance, and business development committees.
- Nasdaq notified company April 6, 2022 that board and audit committee now comply with listing rules 5605(b)(1) and 5605(c)(2)(A).
- Sherwood is principal of Scienta Communications; previously managed communications at The Liposome Company and WeissComm Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/0001558370-22-005126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837022005126/bpth-20220331x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-005126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer